-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
4,4'-Bis(hydroxymethyl)-2,2'-bipyridine, commonly abbreviated as BPM, is a pharmaceutical intermediate used in the production of certain medications such as the anti-malarial drug artesunate.
The synthesis of BPM has been the subject of extensive research due to its complex structure and potential for multiple synthetic routes.
One of the most common synthetic routes for BPM involves the reaction of 4-chloro-2,6-dimethylpyridine with 4- hydroxymethylbiphenyl-2-carboxaldehyde in the presence of a base such as sodium hydroxide.
This reaction results in the formation of 4-hydroxymethyl-2,2'-bipyridine, which can then be further transformed into BPM through a series of chemical reactions such as hydrolysis, methylation, and nitration.
Another synthetic route for BPM involves the reaction of 2,6-lutidine with 4-chloro-2,6-dimethylaniline in the presence of a base such as sodium hydroxide.
This reaction results in the formation of 2,6-dichloro-4-nitroaniline, which can then be transformed into BPM through a series of chemical reactions such as reduction, hydroxylation, and nitration.
A less common synthetic route for BPM involves the reduction of 4,4'-(ethylenedioxy)bis(2,6-dimethylphenyl)methane, also known as mitracarpine, using a reducing agent such as lithium aluminum hydride.
This reaction results in the formation of 4,4'-(ethylenedioxy)bis(hydroxymethyl)phenylmethane, which can then be further transformed into BPM through a series of chemical reactions such as hydrolysis, methylation, and nitration.
The choice of synthetic route for BPM depends on a variety of factors such as the availability and cost of raw materials, the desired yield and purity of the product, and the scale of production.
The synthetic routes described above are only a few examples of the many methods that have been developed for the synthesis of BPM.
One advantage of the synthetic routes for BPM is that they can be performed in a variety of reaction conditions, including both batch and continuous flow methods.
Batch methods involve the preparation of a fixed amount of reactants and reaction conditions, while continuous flow methods involve the continuous flow of reactants and reaction conditions through a reactor.
Batch methods are often used in early stage research and development due to their flexibility and ease of operation.
Continuous flow methods are often used in large scale production due to their ability to efficiently handle large volumes of reactants and to minimize the amount of waste generated.
Another advantage of the synthetic routes for BPM is that they can tolerate a wide range of impurities in the starting materials and reactants, making them versatile and adaptable to different manufacturing conditions.
However, it is important to monitor the purity of the product throughout the synthesis to ensure that the final product meets the desired specifications.
In conclusion, the synthetic routes for 4,4'-Bis(hydroxymethyl)-2,2'-bipyridine are numerous and diverse, and the choice of route depends on various factors such as the desired yield and purity, the scale of production, and the availability and cost of raw materials.
The advantages of these routes include their flexibility, adaptability, and ability to tolerate impurities in the starting materials and reactants.
As the demand for pharmaceutical intermediates such as BPM continues to grow, it is likely that new and innovative synthetic routes will be developed to meet that demand.